ABT

How is ABT doing right now?

In plain terms: ABT is 19.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

ABT (Abbott Laboratories) is 19.8% below its historical peak. Tape reads in a moderate correction, with the last trade at $109.72. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.

What history says at this drawdown

Across all available history, ABT has spent enough trading days in the 20%-to-15% drawdown band to build a large sample (1148 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for ABT

S&P 500 names behave differently from small-caps at the same drawdown level — the Dipsern segmentation is per-ticker, so historical base rates for ABT reflect its own volatility regime, not the market's. Moderate corrections are the highest-information zone for the Dipsern signal: enough drawdown for mean-reversion to matter, not so much that fundamentals are likely broken. Watch the prediction-error column — if past signals at this level were accurate, the current one is more trustworthy.